Tag: Brolucizumab for DME
Brolucizumab (Beovu) Extended-Dosing Innovation for Effective Diabetic Macular Edema Management
Diabetic macular edema (DME) stands as one of the leading causes of vision impairment in individuals with long-standing diabetes. Historically, patients diagnosed with DME...
